1. Home
  2. INTA vs PGEN Comparison

INTA vs PGEN Comparison

Compare INTA & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intapp Inc.

INTA

Intapp Inc.

N/A

Current Price

$43.43

Market Cap

3.3B

Sector

Technology

ML Signal

N/A

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$4.21

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INTA
PGEN
Founded
2000
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
INTA
PGEN
Price
$43.43
$4.21
Analyst Decision
Buy
Buy
Analyst Count
9
4
Target Price
★ $43.00
$13.67
AVG Volume (30 Days)
762.6K
★ 6.8M
Earning Date
10-27-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.12
Revenue
★ $577,805,000.00
$230,981,000.00
Revenue This Year
$14.28
$2,380.31
Revenue Next Year
$14.95
$84.01
P/E Ratio
★ N/A
$34.63
Revenue Growth
★ 14.62
N/A
52 Week Low
$19.01
$3.04
52 Week High
$48.19
$8.98

Technical Indicators

Market Signals
Indicator
INTA
PGEN
Relative Strength Index (RSI) 48.89 31.74
Support Level $24.91 $3.89
Resistance Level $44.33 $4.41
Average True Range (ATR) 2.03 0.36
MACD -0.42 -0.01
Stochastic Oscillator 40.88 16.78

Price Performance

Historical Comparison
INTA
PGEN

About INTA Intapp Inc.

Intapp Inc is a provider of AI-powered solutions for professional firms in regulated industries. Its vertically tailored solutions are purpose-built for the specialized workflows, complex relationship networks, and professional compliance requirements of accounting, consulting, investment banking, legal, private capital, and real assets firms. By applying Firm AI to core processes and data, Intapp helps partners, dealmakers, and advisors drive firm growth, manage compliance, and improve profitability. Its products include AI & Data Platform, Intapp Celeste and Firm AI, and Intapp Integration Service. The Company operates in accounting, consulting, corporate, investment banking and advisory, and other industries. The Company operates in the UK and the US, with maximum revenue from the US.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: